East Anglian audit of pembrolizumab in non-small cell lung cancer

被引：0
|
作者：
Jackson, A. H. [1 ]
Fenn, R. [2 ]
Shotton, R. [3 ]
Williams, A. [1 ]
Treece, S. [4 ]
Gkogkou, P. [2 ]
Tasigiannopoulos, Z. [2 ]
Gilligan, D. [5 ]
Yip, K. [1 ]
机构：
[1] Ipswich Hosp, Oncol, Ipswich, Suffolk, England
[2] Nofolk & Norwich Univ Hosp, Oncol, Norwich, Norfolk, England
[3] Cambridge Univ Hosp, Oncol, Cambridge, England
[4] Peterborough City Hosp, Oncol, Peterborough, Cambs, England
[5] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England
来源：
LUNG CANCER | 2018年 / 115卷
关键词：
D O I：
10.1016/S0169-5002(18)30120-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
94
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [21] Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer
    Marzia Anita Lucia Romeo
    Marina Chiara Garassino
    Lucia Moiola
    Giulia Galli
    Giancarlo Comi
    Vittorio Martinelli
    Massimo Filippi
    Journal of Neurology, 2019, 266 : 3163 - 3166
  • [22] Pembrolizumab in adjuvant therapy in non-small cell lung cancers
    Lefevre, Antoine
    Tissot, Claire
    BULLETIN DU CANCER, 2024, 111 (04) : 334 - 336
  • [23] Audit of chemoradiotherapy (CRT) in locally advanced non-small cell lung cancer
    Wong, S. -L.
    Morley, T.
    Meng, K.
    Mahmood, W.
    Forster, M.
    Mendes, R.
    LUNG CANCER, 2015, 87 : S53 - S53
  • [24] Local Ablative Therapy Combined with Pembrolizumab in Oligometastatic Non-Small Cell Lung Cancer
    Lee, Hye In
    Choi, Eun Kyung
    Kim, Su Ssan
    Shin, Young Seob
    Park, Junhee
    Choi, Chang-Min
    Yoon, Shinkyo
    Kim, Hyeong Ryul
    Song, Si Yeol
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1634 - S1635
  • [25] Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA
    Samant, T. S.
    Struemper, H.
    Franzese, R. C.
    Goulooze, B.
    Muliaditan, M.
    Melhem, M.
    Ghosh, S.
    Fastenrath, M.
    Stjepanovic, N.
    Szijgyarto, Z.
    Rathi, C.
    Mantero, A.
    Hanafin, P.
    Zajic, S.
    Yanamandra, N.
    Chung, C-W.
    Vlahovic, G.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S407 - S408
  • [26] Pembrolizumab - Subsequent Lines in Non-Small Cell Lung Cancer: The Experience of a Tertiary Hospital
    China Pereira, N.
    Mendes, A.
    Reis, D.
    Dias, M.
    Coutinho, D.
    Costa, T.
    Silva, E.
    Campainha, S.
    Conde, S.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1072 - S1072
  • [27] Addition of Pembrolizumab to Chemotherapy Improves Survival in Metastatic Non-Small Cell Lung Cancer
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (05) : 387 - 387
  • [28] Neoadjuvant immunochemotherapy of pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Y.
    Yan, B.
    You, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S108 - S109
  • [29] Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancer
    Low, Jia Li
    Huang, Yiqing
    Sooi, Kenneth
    Ang, Yvonne
    Chan, Zhi Yao
    Spencer, Katie
    Jeyasekharan, Anand Devaprasath
    Sundar, Raghav
    Goh, Boon Cher
    Soo, Ross
    Yong, Wei Peng
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (01) : 169 - 176
  • [30] Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Zhang, Ran
    Zhao, Gang
    You, Jian
    HELIYON, 2023, 9 (09)
12345